{"id":"vaccinated-with-sabin-ipv","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (pain, redness, swelling)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sabin IPV is an inactivated (killed) poliovirus vaccine containing chemically inactivated strains of poliovirus types 1, 2, and 3. When administered, it triggers both humoral (antibody) and cellular immune responses without risk of vaccine-strain disease. The vaccine prevents infection by inducing neutralizing antibodies that block viral entry and replication.","oneSentence":"Sabin IPV (inactivated polio vaccine) stimulates the immune system to produce antibodies against all three poliovirus serotypes, preventing poliomyelitis infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:36.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of poliomyelitis (all three poliovirus serotypes)"}]},"trialDetails":[{"nctId":"NCT04529538","phase":"PHASE1","title":"Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines","status":"COMPLETED","sponsor":"PATH","startDate":"2021-03-26","conditions":"Poliomyelitis","enrollment":226},{"nctId":"NCT04576910","phase":"PHASE4","title":"Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China","status":"COMPLETED","sponsor":"Zhejiang Provincial Center for Disease Control and Prevention","startDate":"2020-11-05","conditions":"Polio, Vaccine Reaction","enrollment":387},{"nctId":"NCT04544787","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates","status":"COMPLETED","sponsor":"Pierre Van Damme","startDate":"2018-10-22","conditions":"Poliomyelitis","enrollment":250},{"nctId":"NCT03597919","phase":"PHASE4","title":"A Study of Immunogenicity and Seroconversion With Sabin IPV Schedules in China.","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention, China","startDate":"2018-05-28","conditions":"Poliomyelitis","enrollment":560},{"nctId":"NCT02582255","phase":"PHASE4","title":"A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania","status":"COMPLETED","sponsor":"Fidec Corporation","startDate":"2015-11","conditions":"Poliomyelitis","enrollment":100},{"nctId":"NCT04054492","phase":"PHASE4","title":"To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV","status":"COMPLETED","sponsor":"China National Biotec Group Company Limited","startDate":"2018-03-01","conditions":"Vaccination, Reaction - Vaccine","enrollment":604},{"nctId":"NCT00547248","phase":"PHASE3","title":"Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-10-22","conditions":"Infections, Streptococcal","enrollment":756},{"nctId":"NCT01831050","phase":"PHASE4","title":"Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine","status":"COMPLETED","sponsor":"Fidec Corporation","startDate":"2013-05","conditions":"Poliomyelitis","enrollment":1420}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":48,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"vaccinated with Sabin IPV","genericName":"vaccinated with Sabin IPV","companyName":"Zhejiang Provincial Center for Disease Control and Prevention","companyId":"zhejiang-provincial-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"Sabin IPV (inactivated polio vaccine) stimulates the immune system to produce antibodies against all three poliovirus serotypes, preventing poliomyelitis infection. Used for Prevention of poliomyelitis (all three poliovirus serotypes).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}